Study Archive - MS-Docblog

The Biomarker Serum Neurofilament Light Chains – Some Explanations and Statement on the New Study from Basel

7. March 2022 Prof. Dr. med. Mathias Mäurer Therapy for MS

Currently, both the medical professional press and the lay press are discussing the importance of the so-called Serum Neurofilament Light Chain value (abbreviation: sNfL). This is mainly due to a new study that was recently

Fake Science by Multiple Sclerosis

2. November 2018 Prof. Dr. med. Mathias Mäurer General

This phenomenon is currently being discussed in both the print media and various political magazines on television. Just recently, there was a report on ARD that can still be accessed in the media library (https://www.tagesschau.de/inland/fakescience-101.html).

The Question of the Right Dosage

30. July 2015 Prof. Dr. med. Mathias Mäurer General, MS Therapy

The question of the correct dosage of immunomodulatory drugs has often been discussed in the comments. Many patients do not understand why doctors usually use the full (approved) dose of a drug, even though a

INFORMS Study Negative

6. February 2015 Prof. Dr. med. Mathias Mäurer General

The news has been known since 01.12.2014, but it is still so fresh that it is worth picking up. It is known that the therapy of relapsing MS has received numerous innovations in recent years,

Tag: Study

The Biomarker Serum Neurofilament Light Chains – Some Explanations and Statement on the New Study from Basel

Fake Science by Multiple Sclerosis

The Question of the Right Dosage

INFORMS Study Negative

Thank You!

Recent Posts

Archive

Categories

Links

Follow us

The Expert

The Topics

The Community